Altered expression of GLS2 indicates a poor prognosis and correlates with clinicopathological features of oral squamous cell carcinoma
The objective of this study was to determine whether GLS2 transcription levels are associated with oral squamous cell carcinoma (OSCC) when compared to matched adjacent normal tissues. Primary tumour and adjacent normal tissues were collected from 51 OSCC patients, and GLS2 mRNA expression analysis was conducted using real-time qPCR. Additionally, The Cancer Genome Atlas –Head and Neck Squamous Cell Carcinoma (TCGA-HNSCC) dataset was utilized to examine GLS2 expression in relation to clinicopathological features, the prognosis, and tumour immune cell infiltration.
Source: International Journal of Oral and Maxillofacial Surgery - Category: ENT & OMF Authors: B. Kannan, C. Pandi, A. Pandi, V.P. Jayaseelan, S. Murugan M, P. Arumugam Tags: Research Paper Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | ENT & OMF | Head and Neck Cancer | HNSCC | Oral Cancer | Skin Cancer | Squamous Cell Carcinoma | Study